IQP-VV-102, a Novel Proprietary Composition for Weight Reduction: A Double-Blind Randomized Clinical Trial for Evaluation of Efficacy and Safety

Table 1

Demographic characteristics in intention-to-treat population.

Parameter	Intention-to-treat population (n = 118)		p value
	IQP-VV-102 group; (n = 58); mean (SD)	Placebo group; (n = 60); mean (SD)
Gender
Males	12 (20.7%)	22 (36.7%)	0.055
Females	46 (79.3%)	38 (63.3%)
Age (years)	43.6 (11.6)	40.5 (11.9)	0.163